Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDKL5 Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02318602
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

Who this might be right for
Seizures
INSYS Therapeutics Inc 52
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Testing effectiveness (Phase 2)Ended earlyNCT02815540
What this trial is testing

The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

Who this might be right for
Lennox-Gastaut SyndromeDravet Syndrome
Gillette Children's Specialty Healthcare 2
Large-scale testing (Phase 3)Study completedNCT03572933
What this trial is testing

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency Disorder
Marinus Pharmaceuticals 101
Not applicableStudy completedNCT02229032
What this trial is testing

Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

Who this might be right for
Dravet Syndrome
University of Colorado, Denver 19
Post-approval studies (Phase 4)Study completedNCT05026398
What this trial is testing

Fenfluramine and Cognition

Who this might be right for
Cognitive Function
University of Oxford 56
Not applicableAvailableNCT06149663
What this trial is testing

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeDevelopmental and Epileptic Encephalopathies
Longboard Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02682927
What this trial is testing

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet SyndromeSeizure Disorder
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 262
Large-scale testing (Phase 3)Study completedNCT02823145
What this trial is testing

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 375
Large-scale testing (Phase 3)Active Not RecruitingNCT06660394
What this trial is testing

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Who this might be right for
Dravet Syndrome
Longboard Pharmaceuticals 96
Testing effectiveness (Phase 2)Looking for participantsNCT06401538
What this trial is testing

BMB-101 in Absence Epilepsy and DEE

Who this might be right for
Absence EpilepsyJeavons SyndromeDravet Syndrome+1 more
Bright Minds Biosciences Pty Ltd 20
Large-scale testing (Phase 3)Study completedNCT02224703
What this trial is testing

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 199
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Very early researchLooking for participantsNCT07675746
What this trial is testing

Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome

Who this might be right for
Dravet Syndrome (DS)
Second Affiliated Hospital of Guangzhou Medical University 8
Not applicableStudy completedNCT02705677
What this trial is testing

Biobanking of Rett Syndrome and Related Disorders

Who this might be right for
Rett SyndromeMECP2 DuplicationCDKL5+1 more
University of Alabama at Birmingham 752
Not applicableStudy completedNCT05544058
What this trial is testing

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

Who this might be right for
Dravet Syndrome
Biocodex 100
Large-scale testing (Phase 3)Study completedNCT06118255
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Who this might be right for
Dravet Syndrome
UCB BIOSCIENCES, Inc. 25
Early research (Phase 1)Study completedNCT03467113
What this trial is testing

Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

Who this might be right for
Dravet SyndromeLennox Gastaut Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 9
Next Page